Kwality Pharmaceuticals Ltd — Board Meeting, 10-08-2026: Board Meeting
10-08-2026 | 12:09 pm
10-08-2026 | 12:09 pm
Kwality Pharma (KPL) reports strong Q1 FY27. Revenue rose 46% YoY to ₹162 Cr, and PAT surged 119% to ₹26 Cr. Management upgraded FY27 guidance: Revenue ₹700+ Cr, PAT ₹109+ Cr. R&D is advancing with 13 BE studies completed and new product registrations.
No comments yet. Be the first to comment!
